Physician profile
Ryan Matthew Muchowski
NPI 1265838668
$2,931.85
in general payments reported to CMS, 2019-2025
25 companies · $532 in 2025
The $532 reported for 2025 was more than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $476 · 2020: $460 · 2021: $32.37 · 2022: $220 · 2023: $363 · 2024: $849 · 2025: $532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,409 · Travel and Lodging: $335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,409.24 |
| Travel and Lodging | $335.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $391.50 | 2024 | Hammertube Sterile Implant Kits |
| Zyla Life Sciences, INC. | $328.70 | 2019-2020 | |
| Fidia Pharma USA INC. | $251.42 | 2019-2021 | |
| Medtronic, INC. | $243.70 | 2025 | Abre |
| Kerecis Limited | $207.23 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Assertio Therapeutics, INC. | $188.61 | 2020 | |
| Smith+Nephew, INC. | $180.90 | 2019-2024 | Regranex, Collagenase Santyl |
| Boston Scientific Corporation | $179.70 | 2023-2024 | |
| Horizon Therapeutics Plc | $147.34 | 2022-2023 | Krystexxa |
| Zimmer Biomet Holdings, INC. | $137.55 | 2024 | Activbraid, Juggerknotless Soft Anchor |
| Bioventus LLC | $116.95 | 2023-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Voom Medical Devices, INC. | $111.24 | 2025 | Revcon Instrument Kit, Sterile |
| Ossio INC | $62.12 | 2023 | |
| Next Science LLC | $53.59 | 2023 | Surgx, Xperience, Blastx |
| Merck Sharp & Dohme LLC | $52.36 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $46.00 | 2023-2025 | Spy-Phi System, N/A |
| Baudax Bio INC. | $36.34 | 2020 | |
| Paratek Pharmaceuticals, INC. | $33.71 | 2022-2025 | Nuzyra |
| Curonix LLC | $31.20 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Vertex Pharmaceuticals Incorporated | $30.24 | 2025 | |
| Amgen INC. | $25.89 | 2024 | Krystexxa |
| Acumed LLC | $22.21 | 2022 | |
| Avanos Medical | $20.02 | 2025 | Grpro 2.1 |
| Organogenesis INC. | $17.33 | 2025 | Puraply Wound Matrix |
| Ibsa Pharma INC. | $16.00 | 2025 | Flector, Licart, Tirosint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Muchowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.